In a randomized controlled trial of BRCA@/@ gene-mutation testing in the Ashkenazi Jewish ( AJ ) population , we compared testing all participants in the population screening ( PS ) arm with testing those fulfilling standard FH-based clinical criteria ( FH arm ) .